Aclaris Therapeutics Inc (ACRS) financials · rev $3.6M
Aclaris Therapeutics Inc (ACRS) rev $3.6M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $7.8M | $18.7M |
| Cost of Revenue | $2.1M | $2.8M |
| Gross Profit | $5.7M | $15.9M |
| Operating Income | -$76.4M | -$141.9M |
| Net Income | -$64.9M | -$132.1M |
| EPS (Diluted) | $-0.53 | $-1.71 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $160.5M | $220.3M |
| Current Assets | $96.3M | $126.0M |
| Cash & Equivalents | $20.0M | $24.6M |
| Inventory | $0 | $0 |
| PP&E | $761.0K | $1.0M |
| Total Liabilities | $57.4M | $64.8M |
| Current Liabilities | $28.6M | $31.6M |
| Short-term Debt | $0 | $0 |
| Long-term Debt | $0 | $0 |
| Total Debt | $0 | $0 |
| Shareholders' Equity | $103.1M | $155.6M |
| Retained Earnings | -$967.8M | -$902.9M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$47.1M | -$20.1M |
| CapEx | $111.0K | $121.0K |
| Investing Cash Flow | $48.4M | -$69.8M |
| Financing Cash Flow | -$5.9M | $74.5M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | -$4.6M | -$15.3M |
| Free Cash Flow | -$47.2M | -$20.2M |
FAQ
What is ACRS P/E and revenue?
Aclaris Therapeutics Inc (ACRS) rev $3.6M.
What is ACRS revenue?
Aclaris Therapeutics Inc last cached revenue is $7.8M (FY2025).
Is ACRS profitable?
Aclaris Therapeutics Inc last cached net income is -$64.9M.
What are ACRS total assets?
Aclaris Therapeutics Inc last cached total assets are $160.5M.
What is ACRS free cash flow?
Aclaris Therapeutics Inc last cached free cash flow is -$47.2M.
Not investment advice. Cached statements, not a live tape.